With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Ready for take-off.
SBRT (or ultra-hypofractionation) is now listed as an appropriate fractionation option in the NCCN Guidelines for men with prostate cancer spanning from very-low all the way to very-high risk disease. | NCCN Prostate Version 1.2020